Clinical Trials Logo

Pre-eclampsia clinical trials

View clinical trials related to Pre-eclampsia.

Filter by:

NCT ID: NCT01547390 Terminated - Preeclampsia Clinical Trials

Early Prevention of Preeclampsia Study

EPAPP
Start date: March 2012
Phase: N/A
Study type: Interventional

This is a randomized controlled trial to estimate the efficacy of low dose aspirin for preventing preeclampsia in women identified as high risk. The investigators hypothesize that the risk of preeclampsia in women identified by a first trimester multiparameter predictive model to be at high risk will be significantly reduced by initiating low dose aspirin early in pregnancy.

NCT ID: NCT01538875 Completed - Clinical trials for Hypertension, Pregnancy Induced

Hydralazine Versus Labetalol for the Management of Hypertensive Disorders of Pregnancy

Start date: July 2012
Phase: Phase 3
Study type: Interventional

Hypertensive crisis (defined as a systolic pressure > 160mmHg or a diastolic pressure > 110mmHg) in patients with a hypertensive disorder of pregnancy is a serious complication with severe and even deadly consequences. The management in this population had been studied, but no consensus has been reached with regards to which treatment is better. Our study will compare two drugs: Hydralazine and Labetalol for the management of hypertensive crisis.

NCT ID: NCT01538147 Completed - Clinical trials for Restless Leg Syndrome

Restless Leg Syndrome and Severe Preeclampsia

Start date: August 1, 2017
Phase: N/A
Study type: Observational

Restless Leg Syndrome is a common but not well recognized central nervous system disorder. It is more prevalent during pregnancy and, if present before pregnancy, can develop an exacerbation of symptoms. In some of the hypothesis trying to explain this syndrome, the physiopathology can also explain hypertensive disorders of pregnancy. So far, no study has been done trying to link both disorders.

NCT ID: NCT01538121 Not yet recruiting - Clinical trials for Antiphospholipid Syndrome

Antiphospholipid Antibodies and Early Severe Preeclampsia.

Start date: June 2015
Phase: N/A
Study type: Observational

The Antiphospholipid Syndrome is an immune disease where the presence of antibodies directed against cell membrane phospholipids (antiphospholipid antibodies) can cause an hypercoagulable state that causes thrombosis and obstetric complications (miscarriages, stillbirths). Since 1999 the Sapporo Criteria for Antiphospholipid Syndrome diagnosis includes the development of severe preeclampsia before 34 weeks of gestation, but this was done without solid evidence of a relation between the two. Our study will try to add information to this particular point.

NCT ID: NCT01530230 Completed - Preeclampsia Clinical Trials

ST- Depression on Electrocardiogram During Caesarean Section in Regional Anaesthesia in Women With Preeclampsia

Start date: November 2005
Phase: N/A
Study type: Interventional

The investigators examined whether there was a difference in the occurrence of ST depressions after injection of five or ten units of oxytocin, in preeclamptic patients delivered by caesarean section (CS) under regional anesthesia.

NCT ID: NCT01523327 Recruiting - Clinical trials for Uric Acid and Hypertension in Pregnancy

Study of Association Between Maternal Uric Acid , Maternal and Fetal Outcome in Pregnant Women With Hypertension

Start date: October 2011
Phase: N/A
Study type: Observational

Association of maternal uric acid with maternal condition and fetal outcome in pregnant women with hypertension.

NCT ID: NCT01519297 Suspended - Preeclampsia Clinical Trials

Preeclampsia: A Marker for Future Cardiovascular Risk in Women

Start date: May 2012
Phase: N/A
Study type: Interventional

This study will compare blood vessel and hormone differences between women who have a history of a pregnancy complicated by preeclampsia or high blood pressure, and women who have a history of uncomplicated pregnancy in the last 10 years. The investigators hypothesize that postpartum women with history of preeclampsia will have altered blood vessel function and abnormal hormone levels compared with postpartum women with history of uncomplicated pregnancy. This study will take place over the course of 2 weeks. Each subject will be assessed on a fixed low-salt diet and a fixed high-salt diet. Subjects will have 2 non-invasive blood vessel imaging tests and fasting blood draws.

NCT ID: NCT01501890 Withdrawn - Premature Birth Clinical Trials

Progesterone for First Trimester Vaginal Bleeding

Start date: January 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate whether treatment with progesterone for patients with first trimester vaginal bleeding will alter the rates of obstetrical complications and adverse pregnancy outcomes.

NCT ID: NCT01490489 Completed - Pre-eclampsia Clinical Trials

EG-VEGF : Potential Marker of Pre-eclampsia and / or Intrauterine Growth Restriction

EGEVE
Start date: July 11, 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the potential prognostic value of seric concentrations of EG-VEGF for Pre-eclampsia and/or intrauterine growth restriction and will allow checking whether plasma levels of EG-VEGF at 14-18 weeks of gestation could be proposed as prognostic marker for preeclampsia.

NCT ID: NCT01480544 Completed - Sepsis Clinical Trials

Improving Maternal and Child Health in India: Evaluating Demand and Supply Side Strategies (IMATCHINE)

IMATCHINE
Start date: August 2012
Phase: N/A
Study type: Interventional

The study evaluates the impact of a new conditional cash transfer (CCT) program (Thayi Bhagya Yojana) to promote child birth in obstetric facilities in the state of Karnataka, India in order to determine its policy value and to guide efforts to improve maternal and infant health outcomes nationally. In addition, the study includes a large randomized evaluation of performance-based incentive payments to providers to improve quality of medical care provided during delivery and actual health improvement in the providers' patient populations and their catchment areas.